Brief: Poland's Oncoarendi Therapeutics H1 Net Loss Widens To 4.9 Mln Zlotys
Sept 27 (Reuters) - ONCOARENDI THERAPEUTICS SA OAT.WA :
* H1 NET LOSS 4.9 MILLION ZLOTYS VERSUS LOSS OF 1.3 MILLION
ZLOTYS
YEAR AGO
* H1 REVENUE 0.5 MILLION ZLOTYS VERSUS 0.9 MILLION ZLOTYS
YEAR AGO
* H1 OPERATING LOSS 5.0 MILLION ZLOTYS VERSUS LOSS OF 1.4
MILLION
ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM60hnk2a
Further company coverage: OAT.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments